For example, multiple studies have confirmed that Asian populations consistently retain a lower prevalence in KRAS-mutant lung adenocarcinoma compared to non-Asians with significant differences, the highest of which, to our knowledge, was a 32.9% vs. 9.3% prevalence rate in non-Asian vs. Asian KRAS mutation rates in lung adenocarcinoma patients [40-43]. Here, KRAS is linked to lung adenocarcinoma.